PDX1 and MODY: Similar studies in MODY and neonatal diabetes patients revealed amino acid substitutions within the DBD that are predicted to impair PDX1 target gene activation in development and in mature β cells via decreased DNA binding (10, 135, 152, 153, 154, 155, 156, 157).